Zobrazeno 1 - 10
of 22
pro vyhledávání: '"Adriana Mercan-Stanciu"'
Publikováno v:
BMC Nephrology, Vol 21, Iss 1, Pp 1-9 (2020)
Abstract Background This is a real-world evidence study that aims to analyze the efficacy, tolerability and safety profile of paritaprevir/ombitasvir/ritonavir and dasabuvir, in patients with renal impairment. Methods We conducted an observational pr
Externí odkaz:
https://doaj.org/article/a88e670d7cc74c9bbf2814bfd708e7b6
Autor:
Mihail Cotorogea-Simion, Sebastian Isac, Alina Tita, Letitia Toma, Laura Elena Iliescu, Adriana Mercan-Stanciu, Teodora Isac, Anca Bobirca, Florin Bobirca, Cristian Cobilinschi, Maria Daniela Tanasescu, Gabriela Droc
Publikováno v:
Medicina, Vol 58, Iss 9, p 1147 (2022)
Introduction: Chronic mesenteric ischemia is a rare entity with non-specific symptomatology; combined with rare etiologies, it could lead to unwarranted surgical indication. Case report: We report the case of an 85-year-old woman, with a history of h
Externí odkaz:
https://doaj.org/article/d6d13258fcda4cb789363c0726e28af4
Autor:
GABRIELA DROC, MIRCEA ISTRATE, ADRIANA MERCAN-STANCIU, MIHAI DODOT, TEODORA ISAC, LETITIA TOMA, ANCA ZGURA, ANCA TRIFAN, ANDREEA NICOLETA SERBANICA, LAURA ILIESCU, LAURENTIU MICU
Publikováno v:
In Vivo
Background/Aim: The aim of this study was to determine the safety and efficacy of a direct-acting antiviral treatment, ombitasvir/paritaprevir/ritonavir and dasabuvir, without ribavirin, in a real-life setting. Patients and Methods: We performed a pr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::200b21b3e540efba20cb4fb8bab11378
https://doi.org/10.21873/invivo.13033
https://doi.org/10.21873/invivo.13033
Autor:
Gabriel Cristian Popescu, Razvan Rababoc, Adriana Mercan-Stanciu, Mihai Dodot, Teodora Isac, Letitia Toma, Anca Zgura, Anca Trifan, Andreea Nicoleta Serbanica, Laurentiu Micu, Laura Iliescu
Publikováno v:
Archiv Euromedica. 12
Aim: The aim of this study is to assess the evolution of Fibromax® parameters (fibrosis, inflammation, steatosis, steatohepatitis) in patients with chronic HCV hepatitis at one year after sustained virologic response (SVR) achieved by direct acting
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::87b615b3b8ce5ccbcad66c750b5ca646
https://doi.org/10.35630/2022/12/6.16
https://doi.org/10.35630/2022/12/6.16
Autor:
Andrei Silaghi, Nicolae Bacalbasa, Mihai Dodot, Letitia Toma, Anca Zgura, Razvan Simu, Teodora Isac, Adriana Mercan-Stanciu
Publikováno v:
Clinical and Experimental Medicine
This study aims to evaluate differences in serum and fecal calprotectin in patients with HCV chronic hepatitis and COVID-19 infection and compare them to a control group. This observational study was performed between April 2020 and October 2020 in a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::69f8540536e6d4247aa78236c5baa820
http://europepmc.org/articles/PMC8274470
http://europepmc.org/articles/PMC8274470
Autor:
Adriana Mercan-Stanciu, Anca Zgura, Nicolae Bacalbasa, Daniel Rusie, Dumitru Cristinel Badiu, Letitia Toma, Mihai Dodot, Teodora Isac, Bogdan Haineala, Elena Laura Iliescu, Silviu S Guler-Margaritis, Dragos Serban
Publikováno v:
In Vivo
Background/aim Liver injury has been frequently reported in association with SARS-CoV-2 infection, but data are still lacking regarding the impact of pre-existing liver damage and neoplasia on SARS-CoV-2 infection outcome and vice-versa. This study a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::74f5fb54aa1842cd1a3444377dbb727d
https://doi.org/10.21873/invivo.12636
https://doi.org/10.21873/invivo.12636
Autor:
Adriana, Mercan-Stanciu, Teodora, Isac, Razvan, Rababoc, Daniel, Rusie, Letitia, Toma, Ileana Adela, Vacaroiu, Raluca, Tulin, Elena Laura, Iliescu
Publikováno v:
Cureus.
Direct-acting antivirals (DAAs) opened a new era in the management of hepatitis C virus (HCV)-associated liver disease. However, hepatic cancer screening should not be stopped after obtaining a sustained virologic response (SVR). Current guidelines o
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::22c4c80e872a249f37f207750845bf16
https://doi.org/10.7759/cureus.25487
https://doi.org/10.7759/cureus.25487
Publikováno v:
Cureus. 14(4)
Since its first description, alpha-fetoprotein has become the most widely used marker for diagnosing and monitoring patients with hepatocellular carcinoma (HCC). This study aims to assess the correlation between serum levels of alpha-fetoprotein and
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7229375549c5ae58fffc5713ff754457
https://pubmed.ncbi.nlm.nih.gov/35497085
https://pubmed.ncbi.nlm.nih.gov/35497085
Publikováno v:
BMC Nephrology, Vol 21, Iss 1, Pp 1-9 (2020)
BMC Nephrology
BMC Nephrology
Background This is a real-world evidence study that aims to analyze the efficacy, tolerability and safety profile of paritaprevir/ombitasvir/ritonavir and dasabuvir, in patients with renal impairment. Methods We conducted an observational prospective
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3944b14bd938e68f240b0c83d84f7e8c
https://doaj.org/article/a88e670d7cc74c9bbf2814bfd708e7b6
https://doaj.org/article/a88e670d7cc74c9bbf2814bfd708e7b6
Publikováno v:
Romanian Journal of Laboratory Medicine, Vol 27, Iss 3, Pp 333-337 (2019)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0b67fc454572721c358922fc0d3c3164
https://doaj.org/article/c723675c76bf4c379a3db6a81d91928d
https://doaj.org/article/c723675c76bf4c379a3db6a81d91928d